Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06821113 · ClinicalTrials.gov registry record · NA

Vale+Tú Salud: Corner-Based Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19

A NA study of COVID-19, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT06821113: Recruiting NA study of COVID-19, sponsored by The University of Texas Health Science Center, Houston.

NCT06821113 is a NA study of COVID-19 that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 150 participants, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06821113, a NA study of COVID-19, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the cultural, socioeconomic, inter/personal and work-related factors that influence COVID 19 mitigation practices including social distancing, hand-washing and Personal protective equipment (PPE) use, to adapt, implement, and test Vale+Tú Salud in a cluster randomized trial to assess the extent to which LDL report increased adherence with COVID 19 mitigation practices 1 month post intervention and to promote Vale+Tú Salud just-in-time results and increase its capacity to rapidly disseminate findings among groups that serve LDL and other Latino immigrants.

Conditions Studied

Interventions

  • BEHAVIORAL Standard of Care
  • BEHAVIORAL COVID-19 Group Problem Solving
  • BEHAVIORAL Booster session

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-07-03
Est. Completion 2025-11-01
Phase NA

What NCT06821113 shows while recruiting

NCT06821113 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower).

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 3 interventions - of which Standard of Care is the first listed.

NCT06821113 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06821113 about?

NCT06821113 is a clinical study titled "Vale+Tú Salud: Corner-Based Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19". The purpose of this study is to determine the cultural, socioeconomic, inter/personal and work-related factors that influence COVID 19 mitigation practices including social distancing, hand-washing and Personal protective equipment (PPE) use, to adapt, implement, and test Vale+Tú Salud in a cluster ...

What is the current status of trial NCT06821113?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-07-03. Estimated completion is 2025-11-01.

What conditions does trial NCT06821113 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT06821113?

The interventions under investigation include: Standard of Care (BEHAVIORAL), COVID-19 Group Problem Solving (BEHAVIORAL), Booster session (BEHAVIORAL).

Who is sponsoring clinical trial NCT06821113?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06821113 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06821113's enrollment target sits among peer trials

150 173rd of 298 higher than 123 of 298 other COVID-19 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06821113, the US trial registry maintained by the National Library of Medicine. NCT06821113 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.